The Viral Vectors And Plasmid DNA Manufacturing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Viral Vectors And Plasmid DNA Manufacturing Market?
The market size of the viral vectors and plasmid DNA manufacturing industry has experienced significant expansion in recent years. The market valuation is expected to increase from $5.75 billion in 2024 to $7.11 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 23.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Viral Vectors And Plasmid DNA Manufacturing Industry?
The Viral Vectors and Plasmid DNA Manufacturing Global Market is expected to reach a value of $16.52 billion in 2029, growing at a compound annual growth rate (CAGR) of 23.5%.
Download Your Free Sample of the 2025 Viral Vectors And Plasmid DNA Manufacturing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Viral Vectors And Plasmid DNA Manufacturing Market?
The key drivers in the viral vectors and plasmid dna manufacturing market are:
• Increasing number of gene therapies
• Expanding number of market participants
• Rising rates of infectious diseases and hereditary abnormalities
• Growing investments in cell and gene therapy research
Global Market Segmentation: Identifying Major Viral Vectors And Plasmid DNA Manufacturing Industry Segments
The viral vectors and plasmid dna manufacturing market covered in this report is segmented –
1) By Product Type: Plasmid Deoxyribonucleic Acid (DNA), Viral Vector, Non-Viral Vector
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders, Other Disorders
4) By Application Area: Gene Therapies, Cell Therapies, Vaccines
5) By Type Of Manufacturer: In-house Manufacturers, Contract Manufacturing Organizations
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): Linear Plasmid DNA, Circular Plasmid DNA, High-Copy Plasmid DNA, Low-Copy Plasmid DNA
2) By Viral Vector: Adenoviral Vectors, Lentiviral Vectors, Adeno-Associated Viral Vectors (AAV), Retroviral Vectors
3) By Non-Viral Vector: Liposome-Based Vectors, Polymer-Based Vectors, Nanoparticle-Based Vectors, Electroporation-Based Vectors
Pre-order the 2025 Viral Vectors And Plasmid DNA Manufacturing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Viral Vectors And Plasmid DNA Manufacturing Market?
The key trends in the viral vectors and plasmid dna manufacturing market are:
• Technological advancements are a notable emerging trend.
• The field is also being shaped by advances in gene therapy.
• The adoption of advanced technologies is becoming increasingly prevalent.
• The use of single-use technologies and advancements in vaccine technology are other important trends.
Who Are the Top Competitors & Leading Players in the Viral Vectors And Plasmid DNA Manufacturing Market?
Major players in the viral vectors and plasmid dna manufacturing market are:
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Astellas Pharma Inc.
• Lonza Group AG
• Catalent Inc.
• Revvity Inc.
• Wuxi Biologics Inc.
• BioMarin Pharmaceutical
• FUJIFILM Diosynth Biotechnologies
• Miltenyi Biotec GmbH
• Aldevron LLC
• Takara Bio Inc.
• Poseida Therapeutics Inc.
• RegenxBio Inc.
• Cobra Biologics
• Finvector Vision Therapies Limited
• Batavia Biosciences B.V.
• uniQure N.V.
• Addgene Inc.
• BioNTech IMFS GmbH
• Creative Biogene Inc.
• Genezen Laboratories Inc.
• Virovek Incorporation
• Waisman Biomanufacturing
• Axplora GmbH
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the viral vectors and plasmid DNA manufacturing market in 2024
